KRMC offers monoclonal antibody therapy to eligible patients. This treatment can help fight COVID-19 infection early.
The therapy, which involves a one-time intravenous (IV) infusion of the antibodies, is available to the following:
- Individuals who have tested positive for COVID-19 and are within ten days of onset
- Unvaccinated individuals who have had close contact with a COVID-positive person
- Vaccinated individuals who are immunocompromised and have had close contact with a COVID-positive person
Early intervention with this treatment can shorten the duration of symptoms and reduce the risk of severe illness and hospitalization.
If you or a close contact test positive for COVID-19, call (928) 681-8699 to see if you are eligible for monoclonal antibody therapy.
Watch the video below to learn more about this therapy and its benefits for treating COVID-19.